找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Biologic Therapy of Leukemia; Matt Kalaycio Book 2003 Springer Science+Business Media New York 2003 antibody.cytokine.cytokines.dendritic

[復(fù)制鏈接]
樓主: Blandishment
41#
發(fā)表于 2025-3-28 17:22:56 | 只看該作者
42#
發(fā)表于 2025-3-28 20:06:47 | 只看該作者
Franz J. Frei,Thomas Erb,Robert Sümpelmann.. Gene therapy approaches can be divided into the manipulation of reproductive cells to maintain a genetic modification in future generations (germ-line gene therapy) or gene transfer into more differentiated tissues, such as cells of the lung, liver, or brain, or hematopoietic cells (somatic gene
43#
發(fā)表于 2025-3-29 02:02:29 | 只看該作者
Antisense Therapyolecular biology of leukemia has identified a series of target genes whose protein products are integral to the pathogenesis of leukemia. Much of this insight has initially been garnered from cytogenetic observations and clinical correlations. These sentinel discoveries have been bolstered by the availability of genomic and proteomic screening.
44#
發(fā)表于 2025-3-29 04:32:03 | 只看該作者
F. J. Frei,C. Jonmarker,O. WernerMonoclonal antibodies (MAbs) have been studied as a treatment for leukemia for approximately 20 years but have only recently been used successfully. The history of MAb development has been reviewed extensively .. The purpose of this chapter is to review the clinical data supporting the use of unconjugated MAbs in the treatment of leukemia.
45#
發(fā)表于 2025-3-29 09:03:14 | 只看該作者
Unconjugated Monoclonal AntibodiesMonoclonal antibodies (MAbs) have been studied as a treatment for leukemia for approximately 20 years but have only recently been used successfully. The history of MAb development has been reviewed extensively .. The purpose of this chapter is to review the clinical data supporting the use of unconjugated MAbs in the treatment of leukemia.
46#
發(fā)表于 2025-3-29 14:50:40 | 只看該作者
47#
發(fā)表于 2025-3-29 15:57:42 | 只看該作者
48#
發(fā)表于 2025-3-29 19:46:00 | 只看該作者
Matt KalaycioIncludes supplementary material:
49#
發(fā)表于 2025-3-30 01:59:56 | 只看該作者
50#
發(fā)表于 2025-3-30 04:32:00 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 03:18
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
淮安市| 綦江县| 衡阳市| 普陀区| 德阳市| 临漳县| 长兴县| 灌云县| 临城县| 墨江| 酒泉市| 南康市| 开封县| 莱州市| 如东县| 甘谷县| 卢氏县| 嘉义市| 舞钢市| 保定市| 随州市| 乌鲁木齐市| 响水县| 车险| 潜江市| 陇南市| 长汀县| 仪陇县| 凉山| 潮安县| 白水县| 呼伦贝尔市| 阳西县| 洛扎县| 沙雅县| 新晃| 曲阜市| 洛宁县| 灵宝市| 阿拉善左旗| 荆门市|